We are live on ! Find out more
EGLT

Egalet Corporation
EGLT

Delisted

EGLT was delisted on the 18th of September, 2018.

36 hedge funds and large institutions have $38.6M invested in Egalet Corporation in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more capital invested

Capital invested by funds: $23.4M → $38.6M (+$15.3M)

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

8% less funds holding

Funds holding: 3936 (-3)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
12
Reduced
9
Closed
5
Calls
Puts
Net Calls
Net Calls Change

EGLT Hedge Fund Activity: Q4 2014 in Review

36 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Egalet Corporation (EGLT) for Q4 2014, worth a combined $38.6M — up 65% from $23.4M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of EGLT and 3 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 12 added.

The largest buyer was Fidelity Investments, adding an estimated $1.14M. The largest seller was Millennium Management, cutting an estimated $1.19M.

  • 36 institutional investors held Egalet Corporation (EGLT) as of Q4 2014, down from 39 in Q3 2014.
  • Funds reported $38.6M of Egalet Corporation stock for Q4 2014, up 65% quarter-over-quarter.
  • 3 funds opened new Egalet Corporation positions in Q4 2014 and 5 closed out, a net change of -2 holders.
  • The largest Egalet Corporation buyer in Q4 2014 was Fidelity Investments, an estimated $1.14M added.
  • The largest Egalet Corporation seller in Q4 2014 was Millennium Management, an estimated $1.19M sold.

Based on aggregated 13F filings for Q4 2014.